DE3533563A1 - MEP AIDS composition - Google Patents

MEP AIDS composition

Info

Publication number
DE3533563A1
DE3533563A1 DE19853533563 DE3533563A DE3533563A1 DE 3533563 A1 DE3533563 A1 DE 3533563A1 DE 19853533563 DE19853533563 DE 19853533563 DE 3533563 A DE3533563 A DE 3533563A DE 3533563 A1 DE3533563 A1 DE 3533563A1
Authority
DE
Germany
Prior art keywords
aids
mep
aids composition
sebifera
myristica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853533563
Other languages
German (de)
Inventor
Michael Birzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19853533563 priority Critical patent/DE3533563A1/en
Publication of DE3533563A1 publication Critical patent/DE3533563A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

In the disease AIDS there is collapse of the immune defences of the body. An increase in the immune response to AIDS pathogens is achieved by a combination of Myristica sebifera (juice of the bark of the tallow nutmeg tree) Echinacea (coneflower) Phytolacca (pokeweed root) d

Description

Bei der Erkrankung AIDS bricht die Immunabwehr des Körpers zusammen. Diese Erkrankung führte bisher nach langem Leiden zum Tode. Viele Menschen sind Träger des AIDS-Erregers ohne daß diese Erkrankung ausbricht weil das Immunsystem noch funktioniert.In AIDS, the immune system breaks down Body together. So far, this disease has resulted to death after long suffering. Many people are Carrier of the AIDS pathogen without this disease breaks out because the immune system is still working.

Die Aufgabe der Erfindung besteht darin ein Mittel zu finden, das bei AIDS eine Anregung der Immunabwehr bewirkt.The object of the invention is a means to find that in AIDS a stimulation of the immune system causes.

Gelöst wird die Aufgabe durch verabreichung der Arzneimittelkombination:
- Myristica sebifera (Baumrindensaft des Talg-Muskatnußbaumes)
- Echinacea (Sonnenhutpflanze)
- Phytolaga (Wurzel der Kermesbeere)
in Form von Spritzen, Tee, Tropfen, Tabletten usw. Durch Kombination dieser Mittel kommt es zu einer steigerung der körpereigenen Immunabwehr wobei eine starke Immunreaktion gegen den AIDS-Erreger erfolgt und somit diese Krankheit gestoppt wird.The task is solved by administering the drug combination:
- Myristica sebifera (sap of the tallow nutmeg tree)
- Echinacea (coneflower plant)
- Phytolaga (pokeweed root)
in the form of syringes, tea, drops, tablets, etc. By combining these agents there is an increase in the body's immune defense, whereby there is a strong immune reaction against the AIDS pathogen and thus this disease is stopped.

Claims (1)

AIDS-Mittel, enthaltend:
- Sonnenhutpflanze (Echinacea)
- Baumrindensaft des Talg-Muskatnußbaumes (Myristica sebifera)
- Wurzel der Kermesbeerenpflanze (Phytolaga)AIDS remedy containing:
- Coneflower plant (Echinacea)
- Tree bark sap from the tallow nutmeg tree (Myristica sebifera)
- Root of the pokeweed plant (Phytolaga)
DE19853533563 1985-09-20 1985-09-20 MEP AIDS composition Withdrawn DE3533563A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19853533563 DE3533563A1 (en) 1985-09-20 1985-09-20 MEP AIDS composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853533563 DE3533563A1 (en) 1985-09-20 1985-09-20 MEP AIDS composition

Publications (1)

Publication Number Publication Date
DE3533563A1 true DE3533563A1 (en) 1987-03-26

Family

ID=6281475

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853533563 Withdrawn DE3533563A1 (en) 1985-09-20 1985-09-20 MEP AIDS composition

Country Status (1)

Country Link
DE (1) DE3533563A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120296A1 (en) * 1991-06-28 1992-03-19 Regina Tilgner Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.
EP0606039A1 (en) * 1993-01-08 1994-07-13 Adrien Guy Perez Composition containing plant saps and plant extracts
EP0980203A1 (en) * 1997-03-26 2000-02-23 Meryl Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
RU2481119C1 (en) * 2012-03-05 2013-05-10 Закрытое акционерное общество "Институт экспериментальной фармакологии" Peptide, amino acid and phospholipid rich agent

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4120296A1 (en) * 1991-06-28 1992-03-19 Regina Tilgner Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.
US7071233B2 (en) 1991-11-13 2006-07-04 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases
EP0606039A1 (en) * 1993-01-08 1994-07-13 Adrien Guy Perez Composition containing plant saps and plant extracts
EP0980203A1 (en) * 1997-03-26 2000-02-23 Meryl Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
EP0980203A4 (en) * 1997-03-26 2004-05-06 Meryl Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
RU2481119C1 (en) * 2012-03-05 2013-05-10 Закрытое акционерное общество "Институт экспериментальной фармакологии" Peptide, amino acid and phospholipid rich agent

Similar Documents

Publication Publication Date Title
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
DE3533563A1 (en) MEP AIDS composition
KR960028903A (en) How to make cosmetic pack
FR2712495B1 (en) Application of Óoenotheine B to obtain a medicament intended for the treatment of disorders linked to hyperandrogenism, and the pharmaceutical compositions containing it.
DE68928415D1 (en) METHOD AND COMPOSITIONS FOR ADMINISTRATING LIPOPHILE MEDICINES IN A DOSAGE AFTER THE DESIRED EFFECT
RU93011229A (en) BIOMASS FOR HAIR REMOVAL
DE3823395A1 (en) Cloth impregnated with an active substance
DE4236069A1 (en) Homeopathic medicaments for treating HIV infections - prepd. by dilution of infected serum
Friedberg et al. Über die Tachyphylaxie der Anaphylatoxinreaktion und ihre Bedeutung für die Anaphylaxie
GB1065910A (en) Purified extracts of gleditsia species and compositions thereof
Strässle et al. Therapieversuche an einem Fall von idiopatischer Positionshypotonie
DE1492134A1 (en) Shampoos
DE1947222A1 (en) Dosage for ionic therapy
Ost Goethes Helena als plastische Gestalt
Chen Über die autolytische Kathepsinwirkung der mit Phosphor oder durch Gallengangunterbindung geschädigten Kaninchenleber
DE19543513A1 (en) Agent for treating human immuno-deficiency virus infection
RU94018748A (en) Medicinal species for treatment of patients with cardiac rhythm disorder
USD194041S (en) Physical conditioning device for facial muscles
DE2148485A1 (en) Health cigarette - with herbal filling
DE4314131A1 (en) Use of equisetum for controlling psoriasis
Anastasopoulos Entstehung und Gestaltung involutiver Psychosen; pp. 321–336
Ishikawa Über den intermediären Kohlehydratstoffwechsel beim Sauerstoffmangel im azidotischen sowie alkalotischen Zustand
DE9400102U1 (en) Fragrance carrier on / in jewelry
KAN UNTERSUCHUNG ÜBER DEN PHOSPHATIDUMSATZ Einfluss der Ultraviolett-und Röntgenbestrahlung der Milz des mit hämolysiertem Blut in jizierten Hundes auf Lipoid-Phosphor, Lipoid-Stickstoff und Lipoid-Amino-Stickstoff im Blut
DE8801310U1 (en) Cosmetic remover of skin impurities

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee